Trials / Sponsors / Kanglin Biotechnology (Hangzhou) Co., Ltd.
Kanglin Biotechnology (Hangzhou) Co., Ltd.
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Β-Thalassemia Treatment with KL003 Cell Injection Transfusion-dependent Beta-Thalassemia | Phase 1 / Phase 2 | 2024-04-05 |